Seoul, South Korea

Se-Jeong Oh

This inventor holds 1 USPTO granted patent. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Se-Jeong Oh. Retrieved from https://idiyas.com/inventor/se-jeong-oh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Se-Jeong Oh: Innovator in Glycoprotein Analysis

Introduction

Se-Jeong Oh is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of bioscience, particularly in the analysis of glycoproteins. His work focuses on understanding the changes in glycosylation that are crucial in tumorigenesis and metastasis.

Latest Patents

Se-Jeong Oh holds a patent for an "Identification method of glycoproteins using a specific lectin precipitation." This innovative method relates to analyzing the changes in glycosylation in various glycoproteins, which play a vital role in cancer development and spread. His patent is a testament to his expertise and dedication to advancing scientific knowledge in this area.

Career Highlights

Se-Jeong Oh is affiliated with the Korea Research Institute of Bioscience and Biotechnology. His work at this esteemed institution has allowed him to collaborate with other talented researchers and contribute to groundbreaking studies in bioscience.

Collaborations

Some of his notable coworkers include Ok-Lye Son and Jeong-Heon Ko. Their collaborative efforts have further enhanced the research output and innovation at the Korea Research Institute of Bioscience and Biotechnology.

Conclusion

Se-Jeong Oh's contributions to glycoprotein analysis highlight his role as an innovator in the field of bioscience. His patent and collaborative work reflect his commitment to advancing research that can have significant implications in understanding cancer biology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…